Post-Conference Perspectives: Understanding HER2-Low Breast Cancer - Episode 3

Treating HER2-low Breast Cancer With Novel Antibody Drug Conjugates

,

Experts take a look at clinical data behind novel antibody drug conjugates and consider how they may impact the management of HER2-low breast cancer.